CA2341708A1 - Medical implant system - Google Patents

Medical implant system Download PDF

Info

Publication number
CA2341708A1
CA2341708A1 CA002341708A CA2341708A CA2341708A1 CA 2341708 A1 CA2341708 A1 CA 2341708A1 CA 002341708 A CA002341708 A CA 002341708A CA 2341708 A CA2341708 A CA 2341708A CA 2341708 A1 CA2341708 A1 CA 2341708A1
Authority
CA
Canada
Prior art keywords
primary controller
muscle
antenna
medical appliance
stimulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002341708A
Other languages
French (fr)
Inventor
Gerard Wolfe Sormann
Simon Michael West
Nicholas Victor Zohan Shuley
Dinesh Kant Kumar
Rodney Bruce Waterhouse
Alan Bernard Bradley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wolfe Research Pty Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPP5732A external-priority patent/AUPP573298A0/en
Priority claimed from AUPP6056A external-priority patent/AUPP605698A0/en
Priority claimed from AUPP8915A external-priority patent/AUPP891599A0/en
Application filed by Individual filed Critical Individual
Publication of CA2341708A1 publication Critical patent/CA2341708A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6867Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive specially adapted to be attached or implanted in a specific body part
    • A61B5/6876Blood vessel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0031Implanted circuitry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/389Electromyography [EMG]
    • A61B5/395Details of stimulation, e.g. nerve stimulation to elicit EMG response
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/6862Stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/378Electrical supply
    • A61N1/3787Electrical supply from an external energy source
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0004Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the type of physiological signal transmitted
    • A61B5/0006ECG or EEG signals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026Measuring blood flow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/389Electromyography [EMG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235Details of waveform analysis
    • A61B5/7264Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
    • A61B5/7267Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems involving training the classification device
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0001Means for transferring electromagnetic energy to implants
    • A61F2250/0002Means for transferring electromagnetic energy to implants for data transfer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37205Microstimulators, e.g. implantable through a cannula

Abstract

There is provided a system for transmission of power and/or information between a first location external of a living body and a second position internal of the living body which comprises: (a) a primary controller (2) comprising a power source and a transmitter locatable at the first locations;
and (b) an antenna (12) based device (10) locatable at the second position to receive an output from the transmitter, wherein the power source is adapted to emit high frequency electromagnetic radiation between 0.5 to 5 GHz. A medical appliance comprising a spring-based stent incorporating a monitoring device wherein the spring of the stent acts as the aerial for the monitoring device and wherein the medical appliance is capable of receiving electromagnetic radiation with a frequency between 0.5 to 5 GHz.

Description

WO 00/13585 PCT/AU99/00 i 26 MEDICAL IMPLANT SYSTEM
Field of the Invention The invention relates to a system which facilitates monitoring. treatment and stimulation of a living body. More particularly, this system relies upon the use of electromagnetic waves as the means of transmission of energy and signals between a device implantable inside the living body and an external control device.
The invention, in a separate embodiment, also relates to a device that may be implanted inside the cardiovascular system so that properties of the environment within the body at which it is implanted may be monitored and a blood flow passage can be enlarged. The device is electrically powered and controlled by an external source of electromagnetic radiation.
Background to the Invention Whilst the following description is in terms of particular applications eg.
muscle stimulation and the use of stems, it is to be understood that the invention has wider application.
A number of people all over the world lose their natural ability to control their muscle contraction and are thus physically disabled. Functional Electrical Stimulation (FES) is a technique which incorporates the stimulation of muscles for providing functionality to people suffering from neuromotor control disorders or have otherwise lost their natural ability to control and contract their muscles usefully. The disorder or loss of natural ability can arise through a range of causes, including disease, trauma or stroke.
FES devices can be classified into two categories - implants and external.
External FES
devices include simple devices such as those used to correct drop foot, and have been in use for a few decades. The implantable devices are relatively new and the first commercialisation of such a device took place in 1997.
In the present art, implantable devices consist of a controller and a set of up to 16 electrodes connected by wires which run inside the body (Memberg, Peckham, Keith, "A
Surgically Implant Intramuscular Electrode for An Implantable Neuromuscular Stimulation System", IEEE trans.Rehab.Eng, vol. 2, no.2, Jun 1994). In this art, the device does not have any internal power source but it is powered by an oscillating magnetic field from the power source coupled with the secondary pick up coil implanted within the patient as a component of the device.
FES devices have been reported which provide this format (L'S Patent No.
~.3~8.s14 to Schulman et al: Matjacic et al "Wireless Control of Functional Electrical Stimulation Systems", PMnD:9148704, UI:9720~71 ~; Sawan, Hassouna et al "Stimulator Desi=n and Subsequent Stimulation Parameter Optimization for Controlling Micturition and Reducing Urethral Resistance". IEEE trans. Rehab.Eng.. vol.4. no.l. Mar 1996). In these devices.
each of the muscle stimulating electrodes is addressable individually. The devices reported have employed frequencies of the magnetic field between 400 h Hz to ~0 M Hz.
It is an intrinsic limitation of such magnetic technologies that the source of the oscillating magnetic field must be close to the pick up coil to efficiently transfer energy by inductive coupling of the magnetic field of the exciting source and the implanted magnetic coil recewer.
1 ~ Some FES systems reported in the prior art provide the forward loop control for the muscles. Devices have been designed which record information from the extremities -either by recording neural activity or by using sensors (like pressure or vibration etc.) and feedback this information to the controller (Haugland. Hoffer et al "Skin Contact Force Information in Sensory Nerve Signals Recorded by Implanted Cuff Electrodes", IEEE
trans.Rehab.Eng.,vol.2, no.l. Mar 1994). Some difficulties associated with these techniques are the invasive nature of their implementation and that further the information received is unnatural so the subjects have to learn to react to this information.
Available devices like the Drop Foot FES system automatically restore the gait of the subject and are not under the conscious control of the subject. FES systems like grasp control devices and other similar systems work under the linear control of the subject.
These latter devices have a number of drawbacks including the need for total visual attention of the subject which restricts the application of the device.
Another drawback is the fact that these devices are not intelligent, unlike the body which has a Peripheral Neuromotor control mechanism which works along with the Central Neural System (CNS).
Thus subjects fitted with the FES devices have to use their CNS to monitor and control the muscle contraction.

WO 00113585 PCT/AL!99/00'26 A number of researchers have proposed systems which provide feedback to the subjects (Haughland, Hoffer et al. "Skin Contact Force Information in Sensoy Nerve Signals Recorded by Implanted CuffElectrodes", IEEE trans. Rehab. Eng. vo I .?, no. 1, Mar I 994;
Hoffer JD, "Closed Loop. Implanted Sensor. Functional Electrical Stimulation System for Partial Restoration of Motor Functions", US Patent No. 4,70.499). These systems primarily utilise invasive methods like recording the neural activiy, embedding sensors inside the body or fixing them on the surface of the body. These techniques are highly invasive and also restrictive to the subjects.
Another known method for muscle stimulation is multi-channel surface FES
systems wherein the electrodes are supported on electrode trousers (MayT, W et al ''EMG-controlled adjustment and fatigue monitoring in mufti-channel surface stimulators"
Proceedings of the Second Annual IFESS Conference (IFESS'97) and Neural Prosthesis: Motor Systems ~
(NP'97) pages I3-14}. Continued investigations, such as this, into external stimulation methods is a result of the above disadvantages of internal systems.
I ~ Accordingly. investigations were carried out to simplify these know highly invasive techniques. In particular, it was felt that if an alternative method could. be developed to communicate between the external control and the internal devices. it may be possible to avoid or limit the use of wires in the body, in particular. to avoid the medically dangerous situation where wires penetrate a~ membrane such as the skin. intestinal walls or arterial walls. The desired alternative method would also pern~it monitoring. treatment and stimulation devices to be placed deeper and more locally to the area of interest in the body.
Various attempts to provide suitable systems and devices have been proposed.
The following patents and patent applications disclose some of these attempts.
United States patent no. x,314,458 The implantable microstimulator system employs a miniature ferrite-cored coil contained within a hermetically sealed housing to receive control signals and operating power from an RF telemetry system. The tiny coil receives the electromagnetic energy which is transmitted from a non-implantable transmitter which generates a code-modulated carrier.
Demodulator circuitry in the implantable microcircuit is employed to extract the control information. while applying the electromagnetic energy to power the electronic circuitry WO 00/13585 PCT/AU99l00'.'26 therein and charge a capacitor which will provide the electrical stimulation to the livin~~
being. The electrical stimulation is delivered by a stimulating electrode which has a waffle-like configuration whereby a pluraliy of iridium oxide electrode pads.
coupled in parallel, so as to be characterised by a long effective edge distance.
transfer the stimulating charge. The electrical components of the microstimulator are contained within a hermetically sealed housing formed of a glass capsule which is electrostaticallv bonded to a silicon substrate.
United States patent no. x,735,887 The citation discloses an implantable, electrically operated medical device system comprising an implantable radio frequency receiver and an external radio frequency transmitter. The system is a closed-loop, inductively coupled radio frequency energy transfer system whereby the transmitted radio frequency power is adjusted up or down by the receiver as a function of received vs. required power, via commands up-linked by the receiver to the transmitter. The subcutaneous receiver incorporates the required faculties to autonomously control all stimulation parameters after it has been programmed only once.
The stimulation parameters controlled by the receiver are pulse amplitude, width and frequency, plus identification of the electrodes to be enabled and their respective polarity.
United States patent no. 5,769,875 This citation discloses a functional neuromuscular stimulation system. The system includes an implanted unit which is powered by the carrier frequency of the transmitted signal and stimulation pulse train decoders. The preferred embodiment uses a frequency of about 10 MHz.
European patent application no. 0 3~3 858 This citation discloses a telemetry system which comprises an implantable element having temperature dependent NMR properties, apparatus for applying a radio frequency field to the implantable element, and apparatus for sensing the temperature dependent NMR
resonance response of the implantabie element and for providing an output indication of temperature of the implantable element. The aim of the citation is to provide a wireless thermometry system useful in clinical hyperthermia. There is disclosure of the implantable elements including a rare earth metal which determines the resonance frequency to be used.

WO 00/13585 PCT/AU99/00~26 As an example. ytrium is said to resonate at approximately ~3.s78 MI-1~
(0.0~_,~ GHz) at 30 decrees C.
US patent no. 3,662.78 discloses a telemetric system which operates at 3~0 kilocycles. A
unit is implanted in the body which is powered by a sowce external of the body. The unit senses resistance between two electrodes inside the body and encodes the resistance as a frequency modulated signal which is then transmitted to a receiver outside of the body.
US patent no. 3,727.616 discloses a telemetric system which operates at 100 KHz. A
receiver totally implanted within a living body is inductively coupled by two associated receiving coils to a physically unattached external transmitter which transmits two signals of different frequencies to the receiver via two associated transmitting coils. One signal provides commands to the receiver and the other signal provides a power source.
US patent no. 4.524,774 discloses a telemetric system which operates at 40.68 to 40.7 MHz. The system includes muscle potential sensors. muscle stimulators and a transmitter-receiver which receive and transmit signals via antennae without being wired to each other.
IS US patent no. 4,102,344 discloses a telemetric system which operates at 300 KHz. The implantable unit has an energy storing device connected t~ electrodes under the control of a transistor which is normally maintained non-conductive as a result of the voltage drop across an impedance connected to the power supply so that each time the power supply is interrupted the transistor becomes conductive to discharge the energy storage device throueh the electrodes.
US patent no. 4,494.90 discloses a telemetric system which operates at 10-~0 KHz. The system consists of a multiplicity of separate modules which collectively perform a useful biomedical purpose; the modules communicating with each other without the use of interconnecting wires. The modules may be intracorporeal or extracorporeal.
Physiological sensor measurements sent from a first module caused a second module to perform some function in a closed loop manner.
US patent no 4,61,443 discloses a telemetric system which operates at frequencies of S I .2 KHz and 48.0 KHz. A two way coherent inductive communications link between an external transceiver and internal transceiver is disclosed which transmits digitally formatted data by frequency shift keying the inductive communications link. Further immediate WO 00/t3585 PCTlAlJ99/00'26 verification of establishment of a reliable communications link is provided by determining the existence of frequency lock and bit phase lock between external and internal transcewers.
US patent no. 4.628,933 discloses a visual prosthesis for implanting in an eve which is powered by telemetn. The prosthesis has a close-packed array of photosensitive devices on one surface thereof. There is disclosure of placing the transmitter about an eyeglass frame lens opening, so that the axis of the transmitting coil is oriented directly toward and in alignment v~~ith the axis of the coil.
US patent no. 4,741.339 discloses a means to improve the electromagnetic coupling between the transmitter and receiver in a telemetric system by using a further coupling coil.
The system requires the transmitter and receiver to be close proximity.
US patent no. 4,932,405 discloses a telemetric system which operates at a frequency between 100-S00 KHz. The system disclosed is for stimulating a nen-e or muscle fibre.
especially a hearing nen~e in the cochlea. The system includes an implant and electrode for 1 S stimulating the nerve which is connected to the implant. The system is powered by a small transformer wherein one coil is implanted and the other is external but in the vicinity of the implanted coil. For supplying information to the implant, infrared transmissions are used wherein the transmitter is provided adjacent to the skin and the receiver on the outside of the body.
US patent no. 5,070.35 discloses a telemetric system designed to improve coupling efficiency between e~aernal transmitter and internal receiver. The citation requires that that receiver and transmitter be in very close proximity.
With the exception of US patent 5.314.458, all of the devices in the above prior art rely on inductive coupling to transfer the energy and are therefore limited in their applications because they must be implanted close to the surface of the body in order to receive the signals from the primary control. The device is US patent 5,314.458 receives electromagnetic radiation of a low frequency (that is, well below 0.~ GHz) and is a bulky device as a result of this low frequency.
There is also a well known art of medical appliances in the form of cylindrical shape with a wire cage called stents. These stmt devices have been developed to enable cardiovascular V~10 00/13585 PCTL4L~99100726 surgeons and cardiologists to introduce these as pan of their treatment to aid healing or relieve an obstruction. The stems are usually initially provided in a collapsed form on an inflatable support. In this form they are introduced into an appropriate blood vessel. such as the femoral artery near the groin. and carefully moved to the site of restricted blood flow.
The supporting balloon is then inflated so deforming the stem spring structure to press outwards into the wall of the blood vessel. The implanting apparatus and the inflatable support is then withdrawn, leaving the expanded stent to maintain the blood vessel open and allow improved blood flow.
It is further desired to combine a stmt and a monitoring and/or stimulating device. In this way, it would be possible to continuously monitor the operation of the heart and provide information to assist preventative therapies to be adopted by a person.
One attempt to combine a stent with a monitoring device is described in PCT
application WO 98/?9030. This application discloses a stmt device which incorporates a device for measuring the fluid flow in the body of the person. The device for measuring blood flow 1 ~ transmits the measurement results to a receiver outside the body.
In one example of this, the stent has a resilient coil made of electrically-conductive material and coupled at both ends to circuitry associated with the flow parameter sensor and/or the transmitter. The energy source outside the body generates a time-varying magnetic field within the vicinity of the coil, which field is preferably aligned with a central axis thereof, this causing an electrical current to flow in the coil and provide energy to the flow parameter sensor and/or transmitter.
The system uses a magnetic coil to create a magnetic field so that a potential is created at right angles to the magnetic field and proportional to the flow rate.
From the formula on page 20 of the citation. the frequency transmitted is about 0.8 MHz which is a low frequency. Again the low frequency gives rise to a bulky device. Further, the ECG recorder is separate from the stem and has sensor electrodes which are externally placed onto the skin rather than implanted.
Description of the Invention It has now been found that there is a range of appropriate frequencies within the electromagnetic spectrum where the radiation penetrates flesh effectively.
This permits the WO 00/13585 PCTiAU99/00~26 transmitter to be separated a con :-enient distance from the receiver that is mam~ times the separation permitted by known coupled magnetic fields.
Accordingly, there is provided a system for transmission of power andior inforntation between a first location external of a living body and a second position internal of the living body which comprises:
(a) a primary controller comprising a power source and a transmitter locatable at the first location: and (b) an antenna based device locatable at the second position to receive an output from the transmitter, wherein the power source is adapted to emit high frequency electromagnetic radiation between 0.5 to 5 GHz.
In particular, the preferred range of high frequency electromagnetic radiation is 0.8 to 2.~
GHz. This high frequency electromagnetic radiation is receivable by the antenna on the implanted device and used as a source of electrical energy to power the device as well as being capable of carrying an information signal to operate the implanted device.
It was surprisingly found that the use of high frequency electromagnetic radiation between 0.5 to S GHz allows significant spatial separation of the primary controller and the implanted device. As such it potentially avoids wires to implanted devices such as stimulating electrodes and permits a number of devices to be implanted deep in the body.
Further, the use of radiation at this frequency removes the need to use coils in the antenna based device because there is no inductive coupling.
It was also found that these high frequencies permitted the use of antennae that were small enough to conveniently implant but still to permit significant penetration of the electromagnetic energy into the body. The antenna format could be, for example, a simple dipole, a loop with or without crenellations, or a microstrip antenna including slot and patch formats. The preferred alternative is a planar omnidirectional format that is integrated into the construction of the device.
Preferably, the primary controller may comprise other devices, for example, a receiver to receive data from the implanted device. In this respect. the implanted device may be used VSO 00/13585 PCTfAI)99100','26 to sense properties of its environment and then transrT:it such data as electromagnetic radiation to the receiver.
Accordingly, it is preferred for the antenna based device to comprise means to monitor predetermined conditions adjacent the antenna based device and to emit signals representative of one or more of these conditions to be received by the primary controller.
By way of illustration only. the device may:
(a) measure the activity of the heart in terms of a electrocardiogram: and (b) transmit this information to the primary controller.
In this way, it is possible to continuously monitor the operation of the heart and provide information to assist preventative therapies to be adopted by a person.
It is also preferred that the antenna based device may itself be a medical appliance which could operate in response to the transmitted signal. For example, the antenna based device could be a stent which is spring based where the spring acts as the antenna.
This device may also be used to derive the data needed to register an electrocardiogram as described 1 ~ above.
According to yet another preferred form. the antenna based device may comprise means to generate pulses of current. By way of illustration only, the device may:
(a) take the transmitted signal, send out pulses for muscle stimulation as specified by the signal regulating commencement time. pulse width, pulse frequency and number of pulses;
(b) measure electrocardiogram (ECG), pCa, glucose, p0,_, pNa, electromyogram (EMG), pH, muscle dimensions and transmit this data to the primary controller;
(c) be a combination of features {a) and (b);
(d) measure the Electroencephalogram inside a cranium to detect abnormal brain conditions such as epilepsy and transmit a signal to the primary controller to activate an alarm;
(e) send out suitable pulses in response to the condition sensed in (d) to trip the brain action back into normal activity.

W0,00/13585 PCT/AU99/00'2ti According to a second aspect of the invention. there is provided a methou for transmitting power and/or information between a first location external of a living body at which a primary controller comprising a power source and a transmitter is located. and a second location inside the living body at which an antenna based device is located.
the method 5 comprises the steps of:
(a) generating high frequency electromagnetic radiation between 0.5 to SGHz from the power source and emitting that radiation from the transmitter of the primary controller: and (b) receiving the radiation at the antenna based device.
10 In particular. the preferred range of the high frequency electromagnetic radiation is 0.8 to 2.5 GHz.
Preferably. the method comprises the further steps of:
(c) powering the antenna based device with the radiation: and/or (d) causing the antenna based device to generate and emit pulses of current;
and/or (e) monitoring predetermined conditions adjacent to the antenna based device and emitting signals representative of one or more of these conditions to be received by the primary controller.
It has also been found that a stem and a monitorin= device may be combined into a single unit thereby achieving two objectives with one operation. Further. the combined device ~ resembles a standard stem. and therefore may be implanted into the patient using the same procedure as for a standard stmt.
According to a third aspect of the invention. a medical appliance is provided which comprises a spring-based stem incorporating a monitoring device wherein the spring of the stent acts as the aerial for the monitoring device and wherein the medical appliance is capable of receiving electromagnetic radiation with a frequency between 0.5 to 5 GHz.
Preferably, the monitoring device is located in the support of the stent.
Preferably, the monitoring device works in conjunction with a primary controller. The monitoring device will preferably comprise means to monitor predetermined conditions in the vicinity the medical appliance and means to emit signals representative of one or more of these conditions to be received by the primary controller.
Preferably, the primary controller is separate and located outside the body in ~~hich the stem is implanted. Preferably, the primary controller is adapted to emit high frequency electromagnetic radiation between 0.~ to 5 GHz. This is particularly useful for deep implants. Preferably, the primary controller is a power source for the monitoring device.
In situations where it is difficult to communicate directly with the medical appliance. a second intermediate implant may be necessary which is closer to the skin surface and which can relay the power and instructions from the primary controller to the medical appliance.
Detailed Description of the Invention Whilst the following discussion is in terms of using the above system and method for stimulation purposes, it will be understood from the discussion above that the invention is not so limited. The invention provides a system of interaction between a location outside the living body and a location inside the living bode which permits power and/or information to flow therebetween. The nature of the information and use of power will depend upon the antennae based device implanted in the livinfi body.
In a first example of the invention. there is provided a stimulation device for providing artificial electrical stimulation comprising a receiver antenna for receiving electromagnetic radiation ranging from between 0.~ to 5 GHz from a primary controller, a supply circuit for deriving electrical energy from the received electromagnetic radiation. an isolating circuit for isolating data signals from the received electromagnetic radiation. a pulse generator for generating electrical pulses according to the data signals utilising the electrical energy from the supply circuit, and a stimulating electrode for outputting the electrical pulses from the pulse generator. .
In other words, this stimulation device comprises an antenna for receiving electromagnetic radiation in the range between 0.5 to 5 GHz from a primary controller and converting it to an oscillating current, a converter for converting the oscillating current to an electrical supply suitable to provide power for the device. an isolating circuit for separating a data I?
signal from the oscillating current. and a pulse generator activated according to the data signal to provide electrical stimulation pulses using said electrical suppy power The stimulation device may therefore be at least substantially encapsulated in a biocompatible material, such as a suitable epoxy. silicone polymer. "diamond"
coating or the like. The stimulating electrode can be constructed from a suitable biocompatible conductive material, such as titanium, surgical stainless steel, gold. osmium, iridium and platinum. The components of the stimulation device may be contained in a single substantially encapsulated unit for ease of surgical implantation, however it is possible that the antenna and/or electrode be separate and connected to the remainder of the device by way of a short wire, for example. This construction may be desirable where the site to be stimulated by the device (i.e. the desired position of the electrode) is located relatively deep within the subject tissue. The concept of the invention would permit the antenna to be near the tissue surface for reduced attenuation of the electromagnetic radiation received at the antenna. It may additionally be desirable to provide a coating or patch of an anti reflection I ~ material on the tissue surface over the antenna to further reduce electromagnetic radiation signal attenuation.
In another example of the invention, a plurality of stimulation devices are used and arc responsive to signals from a single primary controller. In this case, it is desirable for each stimulation device, or groups of stimulation devices. to be selectively actuated by the received data signals. Accordingly. the isolating circuit or pulse generator is preferably constructed to be addressable by certain data signals, such that stimulation pulses are only generated if a certain form of data signal is received from the primary controller. For example, the stimulation device can be constructed to decode modulated digital codes and compared with predetermined codes to ascertain whether that particular device is being addressed. Alternatively, a form of frequency signal coding can be used. and the isolating circuit adapted to isolate only the data signals intended for that device.
Other data encoded in the data signals can be utilised by the pulse generator to control the characteristics of electrical pulses generated, such as pulse shape. magnitude, duration and frequency.
Most patients require several devices to stimulate various muscles and sense their condition and this may be achieved by the central primary controller sending the signals that contain WO 00/13585 PCT/AU99/00?26 addresses of the particular electrod;,s to be activateu or the transmitted data contains related addresses.
For example. this invention allows the patient to have the many electrodes required to stimulate walking without the fragile wires crossing joints.
According to a further embodiment of the invention. there is provided an artificial muscle stimulation system comprising at least one stimulating electrode for providing artificial electrical stimulation to a muscle under control of a primary controller capable of transmitting high frequency electromagnetic radiation between 0.~ to ~ GI-Iz.
an EMG
sensor for measuring EMG signals from the muscle during stimulation, a neural network processor coupled to receive the measured EMG signals to extract information re_arding force of contraction and fatigue of the muscle, and wherein the primary controller is coupled to an output of the neural network processor to control said artificial electrical stimulation based on said extracted information.
It has been discovered that particular muscles rapidly tire if stimulated incorrectly but this I S may be avoided if the muscle is stimulated in different re;ions or less frequently. The art of stimulating muscles requires careful monitoring of several aspects to avoid tiring. It has been discovered that the EMG of the working muscle can be used to characterize the onset of tiring as can extension over time, pressure of the muscle during contraction and the pH
of the tissue of the muscle. The primary controller then varies the stimulation to accommodate the tiring muscle.
It is well known that muscle fatigue is associated with the production of lactic acid rather than carbon dioxide and this is monitored by measuring the pH and p02 of the muscle.
Similarly, with the medical appliance of the third aspect of the invention. it is valuable to measure the glucose concentration and p0~ as the onset of aschemia in a diabetic is indicated when the glucose is high and the p02 is low. This indication with the ECG is useful for diagnosis of a potentially dangerous condition of the patient.
In an embodiment of the third aspect of the invention. the wire spring structure of a stem performs the known basic function of expandins blood vessels, and can also conduct electrical signals and thereby act as the antenna for receiving electromagnetic energy. The small diameter of blood vessels and the reduction in wavelength caused by the high ~'O 00/13585 PCT/AU99100726 permittivity of blood and blood vessel wall. requires that the frequency of the electromagnetic radiation be greater than 0.~ GHz. It has becn surprisingly found that electromagnetic radiation up to for example. a frequency of 1.7 GHz can be usefully transmitted to an antenna that is implanted inside a blood vessel and immersed in blood.
The high frequency electromagnetic radiation causes a typical oscillating current in the wire of the stmt and this current may be modified by designing the inductance and capacitance of the wire structure to induce resonance. The resulting current is rectif ed and used to power the monitoring device.
The direct current is then used to charge either a capacitor or miniature batten. Typically, the circuit would be a low power microprocessor with both A/D
("analogue/digital") inputs and output drivers suitable for generating the pulse train to be applied to the antenna for transmission out of the body. For simple versions of the technology, the function of the microprocessor would be replaced by discrete or partially integrated circuits that perform the function of processing the signals from the sensor, analysing the signal then transmitting the alarm signal.
In this arrangement, the electronics are typically used to monitor the electrocardiogram but may also monitor pH, blood floe, pCa and other metabolites. The device also has provision to transmit signals out of the body, typically to give an alarm for an abnormal condition.
In one practical form of the invention. the stmt is configured as stiff hoops to expand blood vessels but the surgical procedure requires that they be implanted in a collapsed form. Each hoop is pleated with the pleats rou~hl~- sinusoidal so that the amplitude of the sinusoid is normal to the plane of the hoop so making the sinusoidal in the same cylindrical plane as the wall of the blood vessel in which is implanted. The pleating is controlled in amplitude and number of pleats to give a radiation impedance for the antenna similar to the space impedance of the body environment. Similarly, the pleating also gives some control over the inductance and capacitance of the antenna considered as a resonant tank circuit together with the characteristics of the rectifier.

l~
Examples The invention will now be further explained and illustrated by the following non-limiting examples.
Examples 1 to 4 investigate the fabrication of antennae which will receive radiation with a S frequency between 0.5-5 GHz.
Example I
A microwave patch antenna 17 by 17 mm area with a separating dielectric of relative permittivity 10.2 and 1.905 mm thickness was fabricated. coated with Dow Corning Silicone polymer and placed inside a moist piece of fatty tissue/skin at a depth of 10 mm.
The antenna was excited with electromagnetic radiation of S00 milliwatts from a transmitter and the frequency varied near 2.~ GHz to establish the optimum resonant frequency. The power received at the antenna was measured using a microwave power meter when the transmitter was at 12 and 50 cm and found to be 10 mW and 1.6 mW and at l2cm the output of the antenna was recitified with a full wave bridge and showed a I S voltage of 2.~ volts.
Example 2 A microwave patch antenna 29 by 29 mm area with a separating dielectric of relative permittivity 10.2 and 1.90 mm thickness was fabricated, coated with Dow Corning Silicone polymer and placed inside a moist piece of faty tissue/skin at a depth of 10 mm.
The antenna was excited with electromagnetic radiation of 500 milliwatts from a transmitter and the frequency varied near 1.5 GHz to establish the optimum resonant frequency. The power received at the antenna was measured using a microwave power meter when the transmitter was at 12 and ~0 cm and found to be 25 mW and 3.2 mW and at l2cm the output of the antenna was rectified with a full wave bridge and showed a voltage of 2.3 volts. The thickness of the fatty tissue was then increased to 20mm and the test repeated and showed at SO cm a power output of 2.~ mW and at 100 cm a power output of 0.4 mW.

WO 00/13585 PCT~AU99/00~26 Example 3 A microwave patch antenna 33 by 33 mm area with a separating dielectric of relative permittivity 2.2 and 1.58 mm thickness was fabricated, coated with Dow Corning Silicone polymer and placed inside a moist piece of fatty tissue/skin at a depth of 10 mm. The antenna was excited with electromagnetic radiation of 500 milliwatts from a transmitter and the frequency varied near 2.5 GHz to establish the optimum resonant frequency. The power received at the antenna was measured using a microwave power meter when the transmitter was at 12 and SO cm and found to be 10 mW and 0.8 mW and at l2cm the output of the antenna was rectified with a full w°ave bridge and showed a voltage of 2.6 volts.
Example 4 A microwave patch antenna 60 by 60 mm area with a separating dielectric of relative permittivity 2.2 and 1.56 mm thickness was fabricated. coated with Dow Corning Silicone polymer and placed inside a moist piece of fatty tissue/skin at a depth of 10 mm. The 1 ~ antenna was excited with electromagnetic radiation of 500 milliwatts from a transmitter and the frequency varied near 1.5 GHz to establish the optimum resonant frequency. The power received at the antenna was measured usin~ a microwave power meter when the transmitter was at 12, 50 and 100 cm and found to be ?~ mW, 6.3 mW and 0.8 mVv' and at l2cm the output of the antenna was rectified with a full wave bridge and showed a voltage of 2.8 volts. The thickness of the fatty tissue was then increased to 20mm and the test repeated and showed at 50cm a power output of 3.2 mVv' and at 100cm a power output of 0.25 mW.
Summary Examples I to 4 illustrate that radiation with a frequency between 0.5-2.5 GHz can be used to generate power in an antenna based device without the need for inductive coupling.
In Examples ~ to 8 investigations were conducted into the fabrication of devices which could be used in a medical device according to the third aspect of the invention.

w0 OOI13585 PCT/AU99/00'26 Example Surgical stainless steel wire 3l6LVM and diameter 0.0059 in. was pleated with a sinusoid of amplitude 0.039 in. giving five cycles in 0.83 in. This planar structure was then bent to form a hoop and attached to a Schottky diode and measuring apparatus. The entire assembly was coated with a biodegradable resin such as silicone polymer to provide electrical insulation from the biological fluids.
The device was implanted in the artery of a bovine liver and irrigated with heparinised blood. The entire assembly was then transferred to a chamber for testing microwave transmitters and irradiated with electromagnetic energy that was varied in frequency between 0.5 GHz and 2 GHz and the energy received monitored. This test showed satisfactory energy was received up to a frequency of 1300MHz. with several peaks including 850 MHz, and gave an output of 1.5 volts and 400 microwatts when immersed in blood and excited.
It would be understood that a variety of types of wire are useful including titanium and metals in the platinum group, and the wire may have coatings to reduce energy loss by conduction through the body electrolyte and improve the acceptance of the device by the body immune system. Similarly. a wide variety of stem confi~~urations are workable and most of these can be formed into useful antennas.
Example 6 The antenna was constructed with the support of the sinusoidal (or crenellated) loop, supported by an extension of the ends of the loop, at right angles to the main plane of the loop, as parallel wires also contained in the silicone polymer create a capacitance in series with the loop.
The length of the parallel wires was made in 3mm so that when the self inductance of the loop generates an impedance to the oscillating current in the loop wire. it is matched by the impedance of the capacitance and the assembly then causes a tank circuit oscillation with a large increase in available voltage.
The device was tested with radiation at 0.86 GHz and gave 2 volts and 800 microwatts when immersed in blood medium.

WO 00/13585 PCT/AU99/00.26 Is Example 7 The antenna of Example 6 was used to power a Sharp SM~1~3 microprocessor so that the incorporated analog to digital (A/D) converter could be used to input the low frequency signal of an ECG which was simulated on a 1 Hz triangle wave in the blood medium. The output of the microprocessor generated a one bit signal when it had power and had detected the simple signal.
Example 8 The second A/D converter of the microprocessor was used to measure pH by incorporating a miniature pH glass electrode and silver/silver chloride reference electrode . The pH was changed by addition of acid to the blood medium and the microprocessor registered this change by an output of changing output.
Summary Examples ~ to 8 illustrate that a medical appliance can be fabricated which will receive radiation with a frequency between 0.~-~ GHz.
Description of the Drawings The invention will now be further illustrated with reference to the accompanying drawings in which:
Figure 1 is functional block diagram of a wireless electrical muscle stimulation system embodying the first two aspects of the invention;
Figure 2 is a functional block diagram of a receiver and activator for a wireless FES
system;
Figure 3 is a block diagram of a second embodiment of the first two aspects of the tnventton;
Figure 4 is a block diagram showing the construction of a digital form of the receiver 2~ activator;
Figure ~ is a block diagram of a system for providing feedback for artificial stimulation;

WO 00/13585 PCTiAU99/00'26 Figure 6 is a conceptual view of a third embodiment of the first two aspects of the invention:
Figure 7 is a side perspective view of an embodiment of the third aspect of the invention.
As introductory comment to the description of the drawings in Figures 1 to 6.
the antenna based device is a receiver and addressable activating device to enable electrical stimulation of muscles (skeletal, smooth or cardiac] is described below. This receiver is constructed to enable it to be implantable within the body of the subject. and in practice a plurality of receivers would be implanted at different locations in the body to stimulate different muscles. The receiver derives its energy for operation from electromagnetic radiation emanating from a primary controller. The primary controller also provides, by way of the electromagnetic signals having a frequency between 0.~ to S GHz. commands to control the receiver and activator so as to produce appropriate electrical stimulation signals to the muscle.
To enable a wireless FES system to operate with multiple receivers/activators stimulating 1 ~ different muscles and to be controlled by a single primary controller. it must be able to control each receiver/activator individually. To achieve this. each receiver can be constructed to respond only to a certain form of signal issued from the transmitter. There are various ways in which that can be implemented, comprising a digital addressing scheme and a frequency coded addressing scheme. Because the system is wireless, and both power and control signals are transmitted from the primary controller to the multiple receivers by way of the stated electromagnetic radiation, numerous receiver/activators can be controlled using a single primary controller without the difficulties associated with implanted or even external wiring, such as wires passing through jointed areas in the body.
Each receiver comprises an antenna, also implanted, tuned to receive the electromagnetic radiation from a primary controller which may be worn on or about the body of the subject.
As indicated, the high frequency electromagnetic signals are in the range of 0.5 to 5 GHZ.
A portion of the signal energy is utilised to provide electrical power to the activator circuitry, and another portion of the signal is decoded to provide control information such as the address of the receiver/activator and the shape and size of pulse to be provided at the output electrode.

's'1'O 00/13585 PCTlAU99/00'26 This receiver/activator device is preferably encapsulated using a biocompatible resin such as silicone. The output of the activator is a stimulating electrode which is preferably constructed of titanium or a similar biocompatible conductive material. The electrodes are self attaching or may be sutured to the muscle, and can be constructed of a form which are 5 known in the art. The size of each output electrode may be of the order of ?
mm to ?0 mm.
If the muscle to be stimulated is located relatively- deep inside the body, the receiving portion of the device. comprising the antenna. can be located near the surface and provided with a short wire link to the activating site. however it is preferable to select a frequency of the electromagnetic radiation that permits the entire device to be close to the nen~e site 10 being stimulated using electrodes on the surface of the device or very short leads to the stimulating electrodes It may be advantageous to provide a coating or patch of an anti reflection material (suitable for the electromagnetic frequency utilised for communication between the transmitter and receiver) positioned on the skin of the subject where the receiver is located.
if it is desirable 15 to reduce the required level of radiated energy such as for the abdomen area.
Turning to the drawings, Figure 1 is a functional block diagram of a primary controller 2 and receiver 10 system. The receiver and activator device 10 is also illustrated in block diagram form in Figure 2. The device 10 includes a dipole antenna 12 which is constructed to receive electromagnetic signals radiated from the primary controller 2.
Data signals and 20 power is transmitted by the primary controller ? at frequencies which are in the range of 0.5 to S GHz. The dipole antenna 12 can be constructed from a suitable conductive material, such as titanium, or an intebrated circuit die. and may have the dimensions of, for example, 8 mm length, 4 mm width and 2 mm depth. The signals received by the antenna are passed to passive demodulating circuitry 14 of known construction. Signals of one frequency, F,, are thereby demodulated to provide an electrical power source for the activator circuitry 22 24, 26. The electrical power provided by the output of demodulator 14 is used to charge the capacitive storage element 16.
A second frequency, F2, produced by the primary controller 2 is the carrier frequency which carries information responsible for addressing and controlling the specific receiver/activator device 10. Passive filtering circuitry 18 of conventional design can be used to isolate the control signals at carrier frequency F~, which are then demodulated. The w0 00/1358 PCTlAU99/00726 ?1 control signals provide by the output of the demodulator 20 are passed to the activator circuitry ?2. 24, 26.
The activator circuitry portion of the device 10 comprises a digital register and comparator 22 which is able to decode the address portion of the transmitted data. The address is provided to enable selection of one single activation device or a group of devices. and a given activator may be required to be able to decode more than one address (eg one address for the particular device itself and one address for each of group of devices it may belong to). The second burst of pulses is decoded by the devices selected according to the address information, and this provides the information for that device regarding the shape and size of the pulse to be generated at the stimulating electrode. The pulse according to the received data is thus generated by the pulse generator 24, which can also be of conventional form, appears at the electrode plate 26 to stimulate the tissue it is embedded in. The electrode plate may be physically next to the rest of the receiver/activator device 10, or may be a short distance away and coupled thereto by an insulated multistrand stainless steel wire, for example. The device 10 is designed to deliver a variable current from the output electrode 26. This provides the flexibility for use in various different applications. The shape and rate of the train of pulses generated by the pulse generator is dependent on the transmitted signals. and can be dynamically controlled by the primary controller 2 to meet the muscle recruitment requirements. This flexibility is useful in order to be able to have a control over the recruitment of motor units. This is a feature that the existing stimulators have not been able to offer.
In Figure 3. the appropriate activating device is addressed by a choice of modulating tones which is decoded by means of band pass filters 28. In this case, the duration of the tone can be used to determine the width of the pulse to be output by the pulse generator 24. The pulse then appears at the electrode plate 26 and drives a current stimulus through the tissues it is embedded in. Once again. the electrode plate may be physically next to the remainder of the activator device or may be a short distance away and coupled thereto, for example, by an insulated multistrand SS wire.
Figure 4 illustrates in block diagram form a digital implementation of the receiver/activator 30, in which the functions of the signal filtering, demodulation, address decoding and pulse generation are all performed by a single integrated microprocessor and A/D
converter w0 00/13585 PCT/AU99I00726 circuit 34. T he power for the circuit 34 is provided by the power supply circuit 3?. which operates in the same manner as described hereinabove, deriving usable electrical current from the electromagnetic radiation received at the receiver antenna 1?. The functions of the microprocessor and A/D converter circuit are controlled by, for example. micro-coded computer program instructions in a known way. The stimulations pulses to the electrodes 26 are driven directly from the integrated circuit, and this diagram also illustrates the possibility of driving: more than one electrode from a single receiver.
Features of the device described herein include the simple construction which makes it robust and immune to the traumatic environment existing inside the body. There are no coils in the device since inductive coupling is avoided. There are no chemical reactions which is a problem in devices which have charge storage bimetallic capacitors.
Lengthy wires are not required, which makes the surgical implantation procedures vey simple. The device characteristics do not change if there is tissue growth, and a controllable pulse duration and stimulating current is provided for. This is useful in case where the muscle characteristics were to change whether over a long duration of time (eg through aging) or over a short duration (such as through muscle fatigue).
Because the system of the present invention does not require direct wired connections from the primary controller, numerous antenna based devices (eg stimulator devices) can be implanted without the difficulties associated with the wires bypassing joints in the subject.
For example. it is estimated that a minimum of perhaps SO separate artificial stimulators would be required to fully restore a walking function in a subject with disabled motor functions to the legs, and wires to that many stimulator sites would be very problematic.
The present invention provides a system which can, however. easily accommodate that number of receiver/activators, with each individually addressable or addressable in selected groups. For example, with addressing of the receivers by respective digital codes, an eight bit code would enable selective activation of 256 devices and/or groups of devices.
In conjunction with FES stimulation, one further preferred aspect of the present invention also envisages a system which comprises an EMG recorder. an intelligent signal processor and an artificial stimulation controller. The purpose of this overall system is to be able to control the muscle stimulation pattern in order to provide near natural muscle contraction WO 00/13585 PCT/AU99/00 ; 26 for subjects with neuromotor contras disorder. As such this embodiment incorporates the followine features:
(a) EMG measurement from the muscles under stimulation to provide feedback for controlling the artificial stimulation;
(b) processing the EMG measurements using neural network processing to extract information relating to muscle fatigue and force of muscle contraction.
(c) the ability to control the muscle stimulation based on the muscle fatigue status and the net force of contraction being produced by the muscle.
The above features can be implemented in the following manner:
(a) Neural Networks and Time frequency atoms have been used in past to analyse EMG. (Englehart K et al, "Classification of Myoelectric Signal Burst Patterns Using A Dynamic Neural Network", IEEE 199; Hiraiwa A et al, Shimohara K and Tokunga Y. "EMG Pattern Analysis and Classification by Neural Network" IEEE
1989: Jang GC, Cheng FHY, Lai JS and Kuo TS "Using Time Frequency Analysis Technique in the Classification of Surface Emg Signals". IEEE 1994). The present system utilises similar techniques to analyse EMG of the FES stimulated muscles for the purpose of having a closed loop FES system.
(b) During a training phase which is performed under supervision, a fixed stimulation pattern is applied to different electrodes in the same muscle. EMG recordings are memorised by the neural network against the muscle contraction pattern. The system /earns the correlation of the EMG signal, force and fatigue. Fatigue is also taught to a parallel system with the help of the spectrum of the signal.
(c) Thereafter, the system stimulates the same muscle with the help of different pulse shapes and amplitudes and records the force of contraction. The system is self learning and this can continue even when the stimulating device is implanted.
The system incorporates nested neural networks. The network learns the correlation between time, wave shape and strength of contraction.
(d) The trained system receives the EMG signal from the muscles being stimulated.
The system works in a closed loop and with the help of training, it correlates time WO 00/13585 PCT/AU99100?26 EMG wave shape and spectrum with force of cont:action and fatigue. The system then changes the pulse shape and rate of muscle stimulation in order to achieve a constant muscle contraction. The system is thus able to predict and compensate for the muscle fatigue. By suitably selecting a various different sets of electrodes in the same muscle, motor recruitment can therefore be altered and muscle fatieue prevented or reduced.
An example of an implementation of such a system 40 is illustrated in Figure ~. A
stimulation controller 42 is used to artificially stimulate the subject's muscle 54 by way of FES electrodes 52 in order to achieve muscle contraction in the subject. EMG
sensors 48 measure EMG feedback signals from the muscle, which are passed to an analyser circuit 46 and thence to a neural network processor 44. The neural network processor 44 provides electrical feedback to the stimulation controller 42 according to discerned muscle fatigue, ' etc. A joystick ~0 or the like. under control of the subject. can provide physical feedback signals indicative of, for example, muscle contraction. The above described system thus 1 ~ enables a technique for processin, surface EMG using intelligent signal processing techniques incorporating Neural Networks. The technique extracts information related to the status of muscle fatigue and force of the stimulated muscle. The system can therefore provide information related to change in motor recruitment and stimulation in order to maintain constant force of contraction and prevent fatigue. It can also analyse the need by the subject to increase or decrease the force of contraction of any muscle.
With reference to figure 6, the primary controller emits a signal to an implanted device in a leg. The implanted device takes the transmitted signal. decodes it. sends out pulses for muscle stimulation as specified by the signal regulating commencement time, pulse width, pulse frequency and number of pulses. As shown the device also comprises a sensor to measure characteristics such as EMG. pH. and muscle dimensions. It then transmits data to the primary controller. In this way, the system provides a remotely powered device that can be instructed to stimulate muscles and also monitor the state of the muscles.
The medical appiiance 110 in Figure 7 has the basic elements of a known stem, that is, a spring I 11 which is attached to a support I 12. In this case, the support I
12 is a structure capable of incorporating the elements of a monitoring device.

VlrO 00/13585 PCT/AU99/00726 ~5 Due to the function of the spring I 11 as an aerial for the monitoring device which is incorporated into the support I1?. the amplitude of the sinusoidal pleats is kept small enough so that there is not a great deal of overlap between the loops of the sprin~~ in the stem. This prevents overlap of the electromagnetic fields generated by these individual loops.
The support l I? may therefore be at least substantially encapsulated in a biocompatible material, such as a suitable epoxy or the like. The sensors of the monitoring device may be constructed from a suitable biocompatible conductive material, such as titanium.
The medical appliance 110 in Figure 7 is shov~m in its expanded form. Vdhen the medical appliance I 10 is being inserted into place. the spring I 11 will be in a collapsed form (not shown) to allow for easier insertion.
It is to be understood by those skilled in the technology that many variations or modifications in details of design or construction may be made without departing from the essence of the present invention. Therefore, the invention should be understood to 1 ~ comprise all such variations and modifications within its scope. Further, whilst the applications of the invention has been described in relation to the human body, they are equally applicable to other living bodies such as animals.
The word 'comprising' as used in this description does not limit the invention claimed to exclude any variants or additions.

Claims (25)

THE CLAIMS DEFINING THE INVENTION ARE AS FOLLOWS:
1. A system for transmission of power and/or information between a first location external of a living body and a second position internal of the living body which comprises:
(a) a primary controller comprising a power source and a transmitter locatable at the first location; and (b) an antenna based device locatable at the second position to receive an output from the transmitter, wherein the power source is adapted to emit high frequency electromagnetic radiation between 0.5 to 5 GHz.
2. A system according claim 1 wherein the power source in the primary controller is adapted to emit high frequency electromagnetic radiation between 0.8 to 2.5 GHz.
3. A system according to either of claims 1 or 2 wherein the antenna format of the antenna based device is a planar omnidirectional format that is integrated into the construction of the antenna based device.
4. A system according to any of claims 1 to 3 wherein the antenna format of the antenna based device is a simple dipole, a loop with or without crenellations, or a microstrip antenna including slot and patch formats.
5. A system according to any of claims 1 to 4 wherein the primary controller further comprises other devices.
6. A system according to claim 5 wherein the other device in the primary controller is a receiver to receive data from the implanted device.
7. A system according to any of claims 1 to 6 wherein the antenna based device further comprises means to monitor predetermined conditions adjacent the antennae based device and to emit signals representative of one or more of these conditions to be received by the primary controller.
8. A system according to any of claims 1 to 7 wherein the antenna based device further comprises means to generate pulses of current.
9. A system according to any one of claims 1 to 8 wherein the antenna based device is a medical appliance.
10. A system according to claim 9 wherein the antenna based device is a stent.
11. A method for transmitting power and/or information between a first location external of a living body at which a primary controller comprising a power source and a transmitter is located, and a second location inside the living body at which an antenna based device is located, the method comprises the steps of:
(a) generating high frequency electromagnetic radiation between 0.5 to 5 GHz from the power source and emitting that radiation from the transmitter of the primary controller; and (b) receiving the radiation at the antenna based device.
12. A method according to claim 11 wherein the high frequency electromagnetic radiation in step (a) is 0.8 to 2.5 GHz.
13. A method according to either of claims 11 or 12 wherein the method comprises the further steps of:
(c) powering the antenna based device with the radiation; and/or (d) causing the antenna based device to generate and emit pulses of current;
and/or (e) monitoring predetermined conditions adjacent to the antenna based device and emitting signals representative of one or more of these conditions to be received by the primary controller.
14. A medical appliance comprising a spring-based stent incorporating a monitoring device wherein the spring of the stent acts as the aerial for the monitoring device and wherein the medical appliance is capable of receiving electromagnetic radiation with a frequency between 0.5 to 5 GHz.
15. A medical appliance according to claim 14 wherein the monitoring device is located in the support of the stent.
16. A medical appliance according either of claims 14 or 15 wherein the monitoring device further comprises means to monitor predetermined conditions in the vicinity of the medical appliance.
17. A medical appliance according to any one of claims 14 to 16 wherein the monitoring device works in conjunction with a primary controller.
18. A medical appliance according to claim 17 wherein the monitoring device further comprises means to emit signals representative of one or more of these conditions to be received by the primary controller.
19. A medical appliance according to either of claims 17 or 18 wherein the primary controller is separate and located outside the body in which the stent is implanted.
20. A medical appliance according to any one of claims 17 to 19 wherein the primary controller is a power source for the monitoring device.
21. A medical appliance according to claims 17 to 20 wherein the primary controller is adapted to emit high frequency electromagnetic radiation between 0.5 to 5 GHz.
22. A medical appliance according to any one of claims 17 to 21 further comprising an intermediate implant which relays the power and instructions from the primary controller device to the medical appliance.
23. An artificial muscle stimulation system comprising:

(a) at least one stimulating device for providing artificial electrical stimulation to a muscle under control of a primary controller capable of transmitting high frequency electromagnetic radiation between 0.5 to 5 GHz;

(b) an electromyogram sensor for measuring electromyogram signals from the muscle during stimulation; and (c) a neural network processor coupled to receive the measured electromyogram signals to extract information regarding force of contraction and fatigue of the muscle;
wherein the primary controller is coupled to an output of the neural network processor to control said artificial electrical stimulation based on said extracted information.
24. A method for implementing an artificial stimulation system which comprises an electromyogram recorder, an intelligent signal processor and an artificial stimulation controller capable of transmitting high frequency electromagnetic radiation between 0.5 to 5 GHz comprising the steps of:

(a) performing a training phase under supervision wherein a fixed stimulation pattern is applied to different electrodes in the same muscle;
electromyogram recordings are memorized by the neural network against the muscle contraction pattern; and the system learns the correlation of the electromyogram signal, force and fatigue;

(b) thereafter, recording the force of contraction when the same muscle is stimulated with different pulse shapes and amplitudes;
(c) correlating the time electromyogram wave shape and spectrum of electromyogram signals received from the muscle being stimulated with force of contraction and fatigue; and (d) changing the pulse shape and rate of stimulation in order to achieve a constant muscle contraction.
25. A method for transmitting information from a primary controller to an antenna based device comprising the step of using a power signal as a carrier for the information signals.
CA002341708A 1998-09-04 1999-09-03 Medical implant system Abandoned CA2341708A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
AUPP5732 1998-09-04
AUPP5732A AUPP573298A0 (en) 1998-09-04 1998-09-04 Implantable wireless stimulator and stimulation feedback system
AUPP6056 1998-09-22
AUPP6056A AUPP605698A0 (en) 1998-09-22 1998-09-22 Medical implant system
AUPP8915 1999-03-01
AUPP8915A AUPP891599A0 (en) 1999-03-01 1999-03-01 Modified cardiovascular device
PCT/AU1999/000726 WO2000013585A1 (en) 1998-09-04 1999-09-03 Medical implant system

Publications (1)

Publication Number Publication Date
CA2341708A1 true CA2341708A1 (en) 2000-03-16

Family

ID=27158098

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002341708A Abandoned CA2341708A1 (en) 1998-09-04 1999-09-03 Medical implant system

Country Status (10)

Country Link
US (1) US20060161225A1 (en)
EP (1) EP1109490A4 (en)
JP (1) JP2002524124A (en)
CN (1) CN1188081C (en)
BR (1) BR9913610A (en)
CA (1) CA2341708A1 (en)
IL (2) IL141755A0 (en)
NZ (1) NZ510107A (en)
RU (1) RU2226358C2 (en)
WO (1) WO2000013585A1 (en)

Families Citing this family (171)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6289237B1 (en) * 1998-12-22 2001-09-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Apparatus for energizing a remote station and related method
JP2001231187A (en) * 2000-02-15 2001-08-24 Asahi Optical Co Ltd Power supply system
US7011621B2 (en) * 2000-09-29 2006-03-14 Precision Medical Devices, Inc. Body fluid flow control method and device
EP1342289B1 (en) * 2000-10-11 2010-05-19 Alfred E. Mann Foundation for Scientific Research Improved antenna for miniature implanted medical device
DE10055686A1 (en) * 2000-11-03 2002-05-08 Biotronik Mess & Therapieg Device for influencing cell proliferation mechanisms in vessels of the human or animal body
US7214182B2 (en) * 2003-04-25 2007-05-08 Olympus Corporation Wireless in-vivo information acquiring system, body-insertable device, and external device
AU2007203429B2 (en) * 2003-04-25 2009-06-11 Olympus Corporation Radio-type in-subject information acquisition system, device for introduction into subject, and outside-subject device
DE102004014694A1 (en) * 2004-03-25 2005-10-27 Universität Bremen System and device in a tissue of living organisms implantable device for detecting and influencing electrical bio-activity
US8176922B2 (en) 2004-06-29 2012-05-15 Depuy Products, Inc. System and method for bidirectional communication with an implantable medical device using an implant component as an antenna
WO2006010037A2 (en) 2004-07-08 2006-01-26 Deborah Schenberger Strain monitoring system and apparatus
JP2006141993A (en) * 2004-10-19 2006-06-08 Tohoku Univ Cooling apparatus for internal organs
US8001975B2 (en) 2004-12-29 2011-08-23 Depuy Products, Inc. Medical device communications network
US7545272B2 (en) 2005-02-08 2009-06-09 Therasense, Inc. RF tag on test strips, test strip vials and boxes
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US8730031B2 (en) 2005-04-28 2014-05-20 Proteus Digital Health, Inc. Communication system using an implantable device
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
WO2006116718A2 (en) 2005-04-28 2006-11-02 Proteus Biomedical, Inc. Pharma-informatics system
WO2006130488A2 (en) * 2005-05-27 2006-12-07 The Cleveland Clinic Foundation Method and apparatus for in vivo sensing
US20070005141A1 (en) 2005-06-30 2007-01-04 Jason Sherman Apparatus, system, and method for transcutaneously transferring energy
US7780613B2 (en) 2005-06-30 2010-08-24 Depuy Products, Inc. Apparatus, system, and method for transcutaneously transferring energy
US7572293B2 (en) 2005-06-30 2009-08-11 Depuy Products, Inc. Tibial insert and associated surgical method
US7324915B2 (en) * 2005-07-14 2008-01-29 Biosense Webster, Inc. Data transmission to a position sensor
US7730892B2 (en) * 2005-07-29 2010-06-08 Massachusetts Eye & Ear Infirmary Mechanical vestibular stimulator
EP1920418A4 (en) 2005-09-01 2010-12-29 Proteus Biomedical Inc Implantable zero-wire communications system
CN100404004C (en) * 2005-12-16 2008-07-23 清华大学 Interior piezoelectric ceramic intermittent electricity supply device of implantation joint
CN100411596C (en) * 2005-12-16 2008-08-20 清华大学 Bi-directional digital wireless pressure monitoring system for biology implantation joint
US7720547B2 (en) * 2006-01-04 2010-05-18 Kenergy, Inc. Extracorporeal power supply with a wireless feedback system for an implanted medical device
US8181540B2 (en) * 2006-03-28 2012-05-22 University Of Southern California Measurement of sliding friction-induced vibrations for biomimetic tactile sensing
US7878075B2 (en) * 2007-05-18 2011-02-01 University Of Southern California Biomimetic tactile sensor for control of grip
US7658119B2 (en) * 2006-03-28 2010-02-09 University Of Southern California Biomimetic tactile sensor
US8075627B2 (en) 2006-04-07 2011-12-13 Depuy Products, Inc. System and method for transmitting orthopaedic implant data
US8015024B2 (en) 2006-04-07 2011-09-06 Depuy Products, Inc. System and method for managing patient-related data
CN101496042A (en) 2006-05-02 2009-07-29 普罗秋斯生物医学公司 Patient customized therapeutic regimens
US7908014B2 (en) * 2006-05-05 2011-03-15 Alfred E. Mann Foundation For Scientific Research Antenna on ceramic case
US8163027B2 (en) 2006-06-22 2012-04-24 Depuy Products, Inc. Tibial insert having a reinforced keel
US8764839B2 (en) 2006-06-22 2014-07-01 DePuy Synthes Products, LLC Tibial insert having a keel including a bore formed therein
US8114165B2 (en) 2006-06-22 2012-02-14 Depuy Products, Inc. Tibial insert and method for implanting the same
US8540778B2 (en) 2006-06-22 2013-09-24 DePuy Synthes Products, LLC Tibial insert having multiple keels
ES2312256B1 (en) * 2006-06-30 2009-12-22 Universidad Complutense De Madrid MAGNETIC SENSOR DETECTION OF THE DETERIORATION OF CARDIAC PROTESIS AND METHOD OF DETECTION.
WO2008021305A2 (en) * 2006-08-10 2008-02-21 Sirius Satellite Radio Inc. Methods and systems for retransmission of a broadcast signal using a proximity transmitting radiator
US8632464B2 (en) 2006-09-11 2014-01-21 DePuy Synthes Products, LLC System and method for monitoring orthopaedic implant data
US20080077184A1 (en) * 2006-09-27 2008-03-27 Stephen Denker Intravascular Stimulation System With Wireless Power Supply
US20080081965A1 (en) * 2006-09-29 2008-04-03 Philometron, Inc. Foreign body response detection in an implanted device
US8054140B2 (en) 2006-10-17 2011-11-08 Proteus Biomedical, Inc. Low voltage oscillator for medical devices
JP5916277B2 (en) * 2006-10-25 2016-05-11 プロテウス デジタル ヘルス, インコーポレイテッド Ingestible control activation identifier
US8718193B2 (en) 2006-11-20 2014-05-06 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
JP5005331B2 (en) * 2006-12-19 2012-08-22 富士重工業株式会社 Muscle force sensor
EP1935337A1 (en) * 2006-12-21 2008-06-25 Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO An electromagnetic imaging system, a method and a computer program product
MY165368A (en) 2007-02-01 2018-03-21 Proteus Digital Health Inc Ingestible event marker systems
WO2008095185A1 (en) 2007-02-01 2008-08-07 Boston Scientific Neuromodulation Corporation Neurostimulation system for measuring patient activity
EP3236524A1 (en) 2007-02-14 2017-10-25 Proteus Digital Health, Inc. In-body power source having high surface area electrode
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
WO2008112577A1 (en) 2007-03-09 2008-09-18 Proteus Biomedical, Inc. In-body device having a multi-directional transmitter
US8272278B2 (en) 2007-03-28 2012-09-25 University Of Southern California Enhancements to improve the function of a biomimetic tactile sensor
US8469908B2 (en) * 2007-04-06 2013-06-25 Wilson T. Asfora Analgesic implant device and system
US9693708B2 (en) 2007-05-04 2017-07-04 Arizona Board Of Regents For And On Behalf Of Arizona State University Systems and methods for wireless transmission of biopotentials
US8540632B2 (en) 2007-05-24 2013-09-24 Proteus Digital Health, Inc. Low profile antenna for in body device
US8080064B2 (en) 2007-06-29 2011-12-20 Depuy Products, Inc. Tibial tray assembly having a wireless communication device
JP2009048506A (en) * 2007-08-22 2009-03-05 Yoshida Dental Mfg Co Ltd Radio communication medium buried in periodontium
PT2192946T (en) 2007-09-25 2022-11-17 Otsuka Pharma Co Ltd In-body device with virtual dipole signal amplification
EP2215726B1 (en) 2007-11-27 2018-01-10 Proteus Digital Health, Inc. Transbody communication systems employing communication channels
DK2268261T3 (en) 2008-03-05 2017-08-28 Proteus Digital Health Inc Edible event markers with multi-mode communications and systems as well as methods for using them
US20090272814A1 (en) * 2008-05-05 2009-11-05 Recco Systems Ab Passive Transponder and an Item with a Passive Transponder
SG10201702853UA (en) 2008-07-08 2017-06-29 Proteus Digital Health Inc Ingestible event marker data framework
EP2313003B1 (en) 2008-08-13 2016-08-03 Proteus Digital Health, Inc. Ingestible circuitry
JP5289887B2 (en) * 2008-10-20 2013-09-11 テルモ株式会社 Nerve stimulation system
US8682170B2 (en) 2011-05-20 2014-03-25 The Trustees Of Princeton University System and method for broadband RF interference cancellation
US8693810B2 (en) 2008-11-05 2014-04-08 The Trustees Of Princeton University Optical counter-phase system and method of RF interference cancellation
KR101192690B1 (en) 2008-11-13 2012-10-19 프로테우스 디지털 헬스, 인코포레이티드 Ingestible therapy activator system, therapeutic device and method
US9227075B2 (en) * 2008-12-03 2016-01-05 Boston Scientific Neuromodulation Corporation External charger with adjustable alignment indicator
JP2012511961A (en) 2008-12-11 2012-05-31 プロテウス バイオメディカル インコーポレイテッド Judgment of digestive tract function using portable visceral electrical recording system and method using the same
TWI503101B (en) 2008-12-15 2015-10-11 Proteus Digital Health Inc Body-associated receiver and method
US9439566B2 (en) 2008-12-15 2016-09-13 Proteus Digital Health, Inc. Re-wearable wireless device
US9659423B2 (en) 2008-12-15 2017-05-23 Proteus Digital Health, Inc. Personal authentication apparatus system and method
SG172846A1 (en) 2009-01-06 2011-08-29 Proteus Biomedical Inc Ingestion-related biofeedback and personalized medical therapy method and system
MY153758A (en) 2009-01-06 2015-03-13 Proteus Digital Health Inc Pharmaceutical dosages delivery system
WO2010135634A2 (en) * 2009-05-22 2010-11-25 Arizona Board Of Regents For And On Behalf Of Arizona State University Systems, and methods for neurostimulation and neurotelemetry using semiconductor diode systems
US9700712B2 (en) 2009-01-26 2017-07-11 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University Dipolar antenna system and related methods
WO2010111403A2 (en) 2009-03-25 2010-09-30 Proteus Biomedical, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
MX2011011506A (en) 2009-04-28 2012-05-08 Proteus Biomedical Inc Highly reliable ingestible event markers and methods for using the same.
WO2010127051A1 (en) 2009-04-29 2010-11-04 Abbott Diabetes Care Inc. Method and system for providing real time analyte sensor calibration with retrospective backfill
US9149423B2 (en) 2009-05-12 2015-10-06 Proteus Digital Health, Inc. Ingestible event markers comprising an ingestible component
EP2467707A4 (en) 2009-08-21 2014-12-17 Proteus Digital Health Inc Apparatus and method for measuring biochemical parameters
US10716940B2 (en) 2009-10-20 2020-07-21 Nyxoah SA Implant unit for modulation of small diameter nerves
TWI517050B (en) 2009-11-04 2016-01-11 普羅托斯數位健康公司 System for supply chain management
UA109424C2 (en) 2009-12-02 2015-08-25 PHARMACEUTICAL PRODUCT, PHARMACEUTICAL TABLE WITH ELECTRONIC MARKER AND METHOD OF MANUFACTURING PHARMACEUTICAL TABLETS
EP2528550A2 (en) * 2010-01-25 2012-12-05 The Board of Governors for Higher Education, State of Rhode Island and Providence Plantations Systems and methods for providing a neural-machine interface for artificial legs
US9014779B2 (en) 2010-02-01 2015-04-21 Proteus Digital Health, Inc. Data gathering system
BR112012025650A2 (en) 2010-04-07 2020-08-18 Proteus Digital Health, Inc. miniature ingestible device
TWI557672B (en) 2010-05-19 2016-11-11 波提亞斯數位康健公司 Computer system and computer-implemented method to track medication from manufacturer to a patient, apparatus and method for confirming delivery of medication to a patient, patient interface device
US9044616B2 (en) 2010-07-01 2015-06-02 Boston Scientific Neuromodulation Corporation Charging system for an implantable medical device employing magnetic and electric fields
US9610450B2 (en) 2010-07-30 2017-04-04 Medtronics, Inc. Antenna for an implantable medical device
US9333365B2 (en) 2010-07-30 2016-05-10 Medtronic, Inc. Antenna for an implantable medical device
WO2012040401A2 (en) * 2010-09-21 2012-03-29 Somaxis Incorporated Systems for assessing and optimizing muscular performance
FI125006B (en) * 2010-10-29 2015-04-30 Fibrux Oy Method and apparatus for measuring muscle signals
CN103313754B (en) 2010-11-16 2015-09-30 小利兰·斯坦福大学理事会 Be used for the treatment of the system and method for xerophthalmia
US9821159B2 (en) 2010-11-16 2017-11-21 The Board Of Trustees Of The Leland Stanford Junior University Stimulation devices and methods
EP2642983A4 (en) 2010-11-22 2014-03-12 Proteus Digital Health Inc Ingestible device with pharmaceutical product
US8515559B2 (en) 2011-01-28 2013-08-20 Medtronic, Inc. Communication dipole for implantable medical device
EP3685880B1 (en) 2011-01-28 2021-03-24 Stimwave Technologies Incorporated Neural stimulator system
US9199089B2 (en) 2011-01-28 2015-12-01 Micron Devices Llc Remote control of power or polarity selection for a neural stimulator
US8412352B2 (en) * 2011-01-28 2013-04-02 Medtronic, Inc. Communication dipole for implantable medical device
WO2012125425A2 (en) 2011-03-11 2012-09-20 Proteus Biomedical, Inc. Wearable personal body associated device with various physical configurations
AU2012240239B2 (en) 2011-04-04 2017-01-05 Curonix Llc Implantable lead
US9220897B2 (en) 2011-04-04 2015-12-29 Micron Devices Llc Implantable lead
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US8764621B2 (en) 2011-07-11 2014-07-01 Vascor, Inc. Transcutaneous power transmission and communication for implanted heart assist and other devices
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
RU2014106126A (en) 2011-07-21 2015-08-27 Протеус Диджитал Хелс, Инк. DEVICE, SYSTEM AND METHOD OF MOBILE COMMUNICATION
EP3912675A1 (en) 2011-08-12 2021-11-24 Stimwave Technologies Incorporated Microwave field stimulator
TR201802844T4 (en) 2011-09-15 2018-03-21 Andresen Chad Relay module for implant.
US9235683B2 (en) 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
US20130132855A1 (en) * 2011-11-21 2013-05-23 Medtronic, Inc. Medical device communication system with communication controller using interface device
US8903502B2 (en) 2012-05-21 2014-12-02 Micron Devices Llc Methods and devices for modulating excitable tissue of the exiting spinal nerves
AU2013293234B2 (en) 2012-07-23 2017-08-31 Otsuka Pharmaceutical Co., Ltd. Techniques for manufacturing ingestible event markers comprising an ingestible component
US11737896B2 (en) 2012-07-31 2023-08-29 Purdue Research Foundation Wirelessly-powered implantable EMG recording system
US9078743B2 (en) * 2012-08-22 2015-07-14 California Institute Of Technology 3-coil wireless power transfer system for eye implants
US9351648B2 (en) 2012-08-24 2016-05-31 Medtronic, Inc. Implantable medical device electrode assembly
SG11201503027SA (en) 2012-10-18 2015-05-28 Proteus Digital Health Inc Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
US20140125532A1 (en) * 2012-11-08 2014-05-08 University Of Utah Tattooed antennas
CN103028196B (en) * 2012-12-24 2015-07-22 北京理工大学 Reaction type alternative mark inversion (AMI) energy injection device based on incoherent light
EP2938393A1 (en) 2012-12-26 2015-11-04 Micron Devices, LLC Wearable antenna assembly
US11149123B2 (en) 2013-01-29 2021-10-19 Otsuka Pharmaceutical Co., Ltd. Highly-swellable polymeric films and compositions comprising the same
WO2014138709A1 (en) 2013-03-08 2014-09-12 Oculeve, Inc. Devices and methods for treating dry eye in animals
US9717627B2 (en) 2013-03-12 2017-08-01 Oculeve, Inc. Implant delivery devices, systems, and methods
WO2014153124A1 (en) * 2013-03-14 2014-09-25 Micron Devices, LLC Wireless implantable power receiver system and methods
JP5941240B2 (en) 2013-03-15 2016-06-29 プロテウス デジタル ヘルス, インコーポレイテッド Metal detector device, system and method
WO2014151929A1 (en) 2013-03-15 2014-09-25 Proteus Digital Health, Inc. Personal authentication apparatus system and method
US8996137B2 (en) 2013-04-19 2015-03-31 Oculeve, Inc. Nasal stimulation devices and methods
CN105307719B (en) 2013-05-30 2018-05-29 格雷厄姆·H.·克雷西 Local nerve stimulation instrument
US11229789B2 (en) 2013-05-30 2022-01-25 Neurostim Oab, Inc. Neuro activator with controller
EP3005281A4 (en) 2013-06-04 2017-06-28 Proteus Digital Health, Inc. System, apparatus and methods for data collection and assessing outcomes
EP3010583B1 (en) * 2013-06-17 2020-08-05 Nyxoah SA Dynamic modification of modulation throughout a therapy period
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
EP3046621B1 (en) 2013-09-16 2021-05-26 The Board of Trustees of the Leland Stanford Junior University Multi-element coupler for generation of electromagnetic energy
US9270503B2 (en) 2013-09-20 2016-02-23 Proteus Digital Health, Inc. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
JP2016537924A (en) 2013-09-24 2016-12-01 プロテウス デジタル ヘルス, インコーポレイテッド Method and apparatus for use with electromagnetic signals received at frequencies that are not accurately known in advance
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US9770583B2 (en) 2014-02-25 2017-09-26 Oculeve, Inc. Polymer formulations for nasolacrimal stimulation
US10004913B2 (en) 2014-03-03 2018-06-26 The Board Of Trustees Of The Leland Stanford Junior University Methods and apparatus for power conversion and data transmission in implantable sensors, stimulators, and actuators
WO2015171213A1 (en) 2014-05-09 2015-11-12 The Board Of Trustees Of The Leland Stanford Junior University Autofocus wireless power transfer to implantable devices in freely moving animals
CN110665114B (en) 2014-05-12 2022-12-06 斯蒂维科技公司 Remote RF power system with small size transmit antenna
EP3753517B1 (en) 2014-05-18 2022-05-11 Neuspera Medical Inc. Midfield coupler
US20160336813A1 (en) 2015-05-15 2016-11-17 NeuSpera Medical Inc. Midfield coupler
WO2016015025A1 (en) 2014-07-25 2016-01-28 Oculeve, Inc. Stimulation patterns for treating dry eye
KR20170087855A (en) * 2014-08-22 2017-07-31 펄스 테크토닉스 엘엘씨 Automated diagnosis based at least in part on pulse waveforms
ES2809599T3 (en) 2014-10-22 2021-03-04 Oculeve Inc Stimulation devices to treat dry eyes
US10207108B2 (en) 2014-10-22 2019-02-19 Oculeve, Inc. Implantable nasal stimulator systems and methods
US9764150B2 (en) 2014-10-22 2017-09-19 Oculeve, Inc. Contact lens for increasing tear production
US11077301B2 (en) 2015-02-21 2021-08-03 NeurostimOAB, Inc. Topical nerve stimulator and sensor for bladder control
US11291847B2 (en) 2015-06-16 2022-04-05 The Regents Of The University Of Colorado, A Body Corporate Systems and methods for preventing, diagnosing, and/or treating one or more medical conditions via neuromodulation
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
US10426958B2 (en) 2015-12-04 2019-10-01 Oculeve, Inc. Intranasal stimulation for enhanced release of ocular mucins and other tear proteins
US20170207824A1 (en) * 2016-01-14 2017-07-20 Qualcomm Incorporated Methods and apparatus for wirelessly transferring power
US10252048B2 (en) 2016-02-19 2019-04-09 Oculeve, Inc. Nasal stimulation for rhinitis, nasal congestion, and ocular allergies
WO2017143400A1 (en) * 2016-02-26 2017-08-31 Macquarie University Implanted sensing system for joint replacements
WO2017192572A1 (en) 2016-05-02 2017-11-09 Oculeve, Inc. Intranasal stimulation for treatment of meibomian gland disease and blepharitis
TWI728155B (en) 2016-07-22 2021-05-21 日商大塚製藥股份有限公司 Electromagnetic sensing and detection of ingestible event markers
AU2017348094B2 (en) 2016-10-26 2022-10-13 Otsuka Pharmaceutical Co., Ltd. Methods for manufacturing capsules with ingestible event markers
RU2019118600A (en) 2016-12-02 2021-01-11 Окулив, Инк. APPARATUS AND METHOD FOR MAKING DRY EYE SYNDROME PREDICTION AND TREATMENT RECOMMENDATIONS
US10390515B2 (en) * 2017-04-28 2019-08-27 Herdstrong Llc Bolus antenna system
CN107137078A (en) * 2017-05-08 2017-09-08 京东方科技集团股份有限公司 Brain wave detection device and equipment
EP3515554A4 (en) * 2017-08-26 2020-07-01 Xiaoping Li Method and apparatus of modulating neuronal firing frequency at brain functional site in brain
US10953225B2 (en) 2017-11-07 2021-03-23 Neurostim Oab, Inc. Non-invasive nerve activator with adaptive circuit
WO2019103754A1 (en) * 2017-11-22 2019-05-31 The Regents Of The University Of Colorado, A Body Corporate Systems and methods for preventing, diagnosing, and/or treating one or more medical conditions via neuromodulation
SG10201810156PA (en) * 2018-11-14 2020-06-29 Prec Medical Pte Ltd Method and device for measuring anatomical movement of a joint
KR20220025834A (en) 2019-06-26 2022-03-03 뉴로스팀 테크놀로지스 엘엘씨 Non-invasive neural activators with adaptive circuits
WO2021126921A1 (en) 2019-12-16 2021-06-24 Neurostim Solutions, Llc Non-invasive nerve activator with boosted charge delivery
KR20230025284A (en) * 2021-08-13 2023-02-21 주식회사 에스비솔루션 Antenna device for measuring biometric information using dark mode excitation

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3662758A (en) * 1969-06-30 1972-05-16 Mentor Corp Stimulator apparatus for muscular organs with external transmitter and implantable receiver
US3727616A (en) * 1971-06-15 1973-04-17 Gen Dynamics Corp Electronic system for the stimulation of biological systems
US4102344A (en) * 1976-11-15 1978-07-25 Mentor Corporation Stimulator apparatus for internal body organ
DE3130104A1 (en) * 1981-07-30 1983-02-17 Messerschmitt-Bölkow-Blohm GmbH, 8000 München ARRANGEMENT FOR STIMULATING A HUMAN MUSCLE
US4494950A (en) * 1982-01-19 1985-01-22 The Johns Hopkins University Plural module medication delivery system
US4561443A (en) * 1983-03-08 1985-12-31 The Johns Hopkins University Coherent inductive communications link for biomedical applications
AU569636B2 (en) * 1984-09-07 1988-02-11 University Of Melbourne, The Bipolar paired pulse supplied prosthetic device
CA1246680A (en) * 1984-10-22 1988-12-13 James M. Harrison Power transfer for implanted prosthesis
EP0200321A3 (en) * 1985-03-20 1987-03-11 Ingeborg J. Hochmair Transcutaneous signal transmission system
US4628933A (en) * 1985-07-23 1986-12-16 Michelson Robin P Method and apparatus for visual prosthesis
US4837049A (en) * 1986-06-17 1989-06-06 Alfred E. Mann Foundation For Scientific Research Method of making an electrode array
NL8602043A (en) * 1986-08-08 1988-03-01 Forelec N V METHOD FOR PACKING AN IMPLANT, FOR example AN ELECTRONIC CIRCUIT, PACKAGING AND IMPLANT.
US4750499A (en) * 1986-08-20 1988-06-14 Hoffer Joaquin A Closed-loop, implanted-sensor, functional electrical stimulation system for partial restoration of motor functions
US4736752A (en) * 1986-11-28 1988-04-12 Axelgaard Manufacturing Co., Ltd. Transcutaneous medical electrode
US5016635A (en) * 1988-11-29 1991-05-21 Sigmedics, Inc. Of Delaware Control of FNS via pattern variations of response EMG
US5215088A (en) * 1989-11-07 1993-06-01 The University Of Utah Three-dimensional electrode device
US5314458A (en) * 1990-06-01 1994-05-24 University Of Michigan Single channel microstimulator
SE9002493L (en) * 1990-07-24 1991-09-02 Staffan Gunnarsson VEHICLE DEVICE MAINTAINS POSITIONING BY AUTOMATIC FUELING
US5170802A (en) * 1991-01-07 1992-12-15 Medtronic, Inc. Implantable electrode for location within a blood vessel
EP0536858B1 (en) * 1991-09-12 1996-07-24 BIOTRONIK Mess- und Therapiegeräte GmbH & Co Ingenieurbüro Berlin Stimulation system for a skeletal muscle
JPH0576534A (en) * 1991-09-24 1993-03-30 Akihiro Fujimura Information exchange system of brain and computer
US5358514A (en) * 1991-12-18 1994-10-25 Alfred E. Mann Foundation For Scientific Research Implantable microdevice with self-attaching electrodes
JPH05245215A (en) * 1992-03-03 1993-09-24 Terumo Corp Heart pace maker
JP3506770B2 (en) * 1994-04-21 2004-03-15 オリンパス株式会社 Endoscope position detection device
JP2845758B2 (en) * 1994-08-10 1999-01-13 日本電気株式会社 Motor function support system by electrical stimulation
US5769875A (en) * 1994-09-06 1998-06-23 Case Western Reserve University Functional neuromusclar stimulation system
US5626630A (en) * 1994-10-13 1997-05-06 Ael Industries, Inc. Medical telemetry system using an implanted passive transponder
US5583510A (en) * 1994-11-16 1996-12-10 International Business Machines Corporation Planar antenna in the ISM band with an omnidirectional pattern in the horizontal plane
US5870672A (en) * 1996-04-05 1999-02-09 Corsair Communications, Inc. Validation method and apparatus for preventing unauthorized use of cellular phones
DE19617102A1 (en) * 1996-04-19 1997-10-23 Michael Dr Klausing Electronic energy supply method e.g. for pacemaker
US5735887A (en) * 1996-12-10 1998-04-07 Exonix Corporation Closed-loop, RF-coupled implanted medical device
WO1998029030A1 (en) * 1997-01-03 1998-07-09 Biosense Inc. Pressure-sensing stent
US5861019A (en) * 1997-07-25 1999-01-19 Medtronic Inc. Implantable medical device microstrip telemetry antenna
US5967986A (en) * 1997-11-25 1999-10-19 Vascusense, Inc. Endoluminal implant with fluid flow sensing capability
US5995874A (en) * 1998-02-09 1999-11-30 Dew Engineering And Development Limited Transcutaneous energy transfer device
US6141588A (en) * 1998-07-24 2000-10-31 Intermedics Inc. Cardiac simulation system having multiple stimulators for anti-arrhythmia therapy
US6210347B1 (en) * 1998-08-13 2001-04-03 Peter Forsell Remote control food intake restriction device
EP1106202A3 (en) * 1999-11-30 2004-03-31 BIOTRONIK Mess- und Therapiegeräte GmbH & Co Ingenieurbüro Berlin Electrode for intravascular stimulation, cardioversion and /or defibrillation
US6445953B1 (en) * 2001-01-16 2002-09-03 Kenergy, Inc. Wireless cardiac pacing system with vascular electrode-stents

Also Published As

Publication number Publication date
BR9913610A (en) 2001-10-09
CN1188081C (en) 2005-02-09
RU2226358C2 (en) 2004-04-10
US20060161225A1 (en) 2006-07-20
WO2000013585A1 (en) 2000-03-16
EP1109490A1 (en) 2001-06-27
IL141755A0 (en) 2002-03-10
IL141755A (en) 2006-04-10
JP2002524124A (en) 2002-08-06
NZ510107A (en) 2003-03-28
EP1109490A4 (en) 2005-03-02
CN1315846A (en) 2001-10-03

Similar Documents

Publication Publication Date Title
CA2341708A1 (en) Medical implant system
US9610450B2 (en) Antenna for an implantable medical device
US8849416B2 (en) Implantable bio-electro-physiologic interface matrix
Bashirullah Wireless implants
US6447448B1 (en) Miniature implanted orthopedic sensors
US8412352B2 (en) Communication dipole for implantable medical device
US8019419B1 (en) Methods and apparatus for leadless, battery-less, wireless stimulation of tissue
AU2008352005B2 (en) Array of joined microtransponders for implantation
EP1613396B1 (en) Acoustic telemetry apparatus for intrabody communications
US20120296399A1 (en) Array of Joined Microtransponders for Implantation
US9421379B2 (en) Neuromodulation system incorporating multivariate sensing, multivariable pattern recognition, and patient specific adaptation
CN109069819A (en) Promote the pulse generator system of the asynchronous igniting to the neuron pool raised
AU2008329671A1 (en) Implantable transponder pulse stimulation systems and methods
JP2022516839A (en) Ultrasound-based protocol for operating implantable devices
AU758015B2 (en) Medical implant system
CN101087630A (en) Implantable bio-electro-physiologic interface matrix
ZA200101735B (en) Medical implant system.
US9538957B2 (en) Implantable medical device that is configured for movable connection to an implanted trunk and that is able to inductively exchange signals with the trunk
US8565870B2 (en) System of implantable medical devices including a plurality of spaced apart devices and a common bus over which power and operating instructions are distributed to the devices

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued